Fibrosis News and Research

RSS

Fibrosis is the growth of fibrous tissue.

Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment

Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a breakthrough clinical trial application in place of a human placebo group, marking a world-first in lung disease research.

17 Jun 2025

Deep B cell depletion offers new hope for rheumatologic and musculoskeletal diseases

CD19-CAR T-cell treatment is a novel option of deep B cell depletion with promising results across different rheumatologic and musculoskeletal diseases (RMD).

15 Jun 2025

Early clinical events predict disease progression in very early systemic sclerosis

The VEDOSS project has previously shown that 70% of patients with Raynaud's phenomenon and at least one red flag – systemic sclerosis (SSc)-specific antibodies, puffy fingers, or an SSc pattern on nailfold capillaroscopy –will fulfil the 2013 ACR/EULAR SSc criteria within 5 years.

13 Jun 2025

Waist-to-height ratio found to predict liver damage better than BMI

Excess fat mass estimated by waist circumference-to-height ratio predicts the risk of liver damage better than body mass index (BMI) estimated obesity, a new study shows.

11 Jun 2025

Eliminating stellate cells reduces liver metastasis in mouse models

The prestigious journal Hepatology Communications reports on the discovery by the Cancer and Translational Medicine research group of the University of the Basque Country (EHU).

10 Jun 2025

Rising liver disease cases demand immediate attention

During the first meeting of the Global Think-tank on Steatotic Liver Disease, supported by the Barcelona Institute for Global Health (ISGlobal) and held in the Palau Macaya of Barcelona on 5–6 June, more than 100 international experts issued a stark warning: millions of people will continue to go unseen by healthcare systems unless early detection and person-centred care for liver disease are prioritized without delay.

6 Jun 2025

Breakthrough drug delivery system transports genetic therapies directly to the lungs

Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs, opening promising possibilities for patients with conditions like lung cancer and cystic fibrosis.

5 Jun 2025

SIRT6 identified as a critical safeguard of spinal disc health

Low back pain is the most prevalent musculoskeletal condition worldwide and is closely tied to the progressive degeneration of intervertebral discs.

5 Jun 2025

Type 2 diabetes drug shows improvements for patients with progressive liver disease

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical trial from China published by The BMJ today.

5 Jun 2025

Innovative method reveals how titin disruption triggers muscular diseases

A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), led by Jorge Alegre-Cebollada, has developed an innovative method, called TEVs-TTN, for studying the specific mechanical functions of proteins through their controlled cleavage, a process that renders the proteins unable to sense and transmit mechanical force.

5 Jun 2025

AI-designed drug shows early promise for lung fibrosis patients in clinical trial

Researchers report that rentosertib, an AI-discovered TNIK inhibitor, showed promising safety and potential to improve lung function in patients with idiopathic pulmonary fibrosis in a 12-week phase 2a clinical trial. The highest dose group demonstrated a trend toward increased forced vital capacity, especially among patients not receiving standard antifibrotic therapy, supporting further clinical investigation.

4 Jun 2025

Advanced organoid model recreates complex liver architecture

The liver has a unique structure, especially at the level of individual cells. Hepatocytes, the main liver cells, release bile into tiny channels called bile canaliculi, which drain into the bile duct in the liver periportal region.

29 May 2025

Necrosis may hold the key to unlocking longevity and space health solutions

The process of necrosis, a form of cell death, may represent one of the most promising ways to change the course of human aging, disease and even space travel, according to a new study from researchers at UCL, drug discovery company LinkGevity and the European Space Agency (ESA).

29 May 2025

Feds chop enforcement staff and halt rules meant to curb black lung in coal miners

In early April, President Donald Trump gathered dozens of hard-hat-clad coal miners around him in the White House East Room.

29 May 2025

Immune microRNAs drive new frontiers in cardiovascular disease research

Cardiovascular diseases (CVDs) continue to dominate global mortality statistics, with immune dysregulation emerging as a central feature in their pathogenesis.

28 May 2025

Yeast cells offer promising alternative for manufacturing DNase1

The protein DNase1 is one of the oldest biological agents in history: It has been on the market since 1958 and is now used, among other things, to treat cystic fibrosis.

28 May 2025

Large global study links higher alcohol intake to increased pancreatic cancer risk

A pooled analysis of over 2.4 million adults across four continents shows a modest but significant increase in pancreatic cancer risk with higher alcohol consumption. The risk is especially pronounced for beer and liquor, and at higher intake levels in men and women.

25 May 2025

Fibrosis News and Research

Further Reading

Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment

Deep B cell depletion offers new hope for rheumatologic and musculoskeletal diseases

Early clinical events predict disease progression in very early systemic sclerosis

Waist-to-height ratio found to predict liver damage better than BMI

Eliminating stellate cells reduces liver metastasis in mouse models

Rising liver disease cases demand immediate attention

Breakthrough drug delivery system transports genetic therapies directly to the lungs

SIRT6 identified as a critical safeguard of spinal disc health

Type 2 diabetes drug shows improvements for patients with progressive liver disease

Innovative method reveals how titin disruption triggers muscular diseases

AI-designed drug shows early promise for lung fibrosis patients in clinical trial

Advanced organoid model recreates complex liver architecture

Necrosis may hold the key to unlocking longevity and space health solutions

Feds chop enforcement staff and halt rules meant to curb black lung in coal miners

Immune microRNAs drive new frontiers in cardiovascular disease research

Yeast cells offer promising alternative for manufacturing DNase1

Large global study links higher alcohol intake to increased pancreatic cancer risk

New cryogenic mass spectrometry approach reveals inner structure of lipid nanoparticles

Trump’s team cited safety in limiting covid shots. patients, health advocates see more risk.

Integrating phytomedicine and nanotechnology in managing COVID-19 related heart disease

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News